Previous Article | Next Article ![]()
J. Virol., Oct 1995, 6021-6029, Vol 69, No. 10
JK Wakefield, AG Wolf and CD Morrow
The initiation of human immunodeficiency virus type 1 (HIV-1) reverse
transcription occurs at a site in the viral RNA genome which is designated
the primer-binding site (PBS). The HIV-1 PBS is an 18- nucleotide sequence
that is complementary to the 3'-terminal 18 nucleotides of tRNA(3Lys),
which is used as the primer for reverse transcription. All HIV-1 isolates
sequenced to date contain a PBS complementary to tRNA(3Lys), suggesting
that other cellular tRNAs might not function as primers for reverse
transcription. To investigate this possibility, we have substituted the
HIV-1 PBS with sequences predicted to be complementary to the 3'-terminal
nucleotides of tRNA(1,2Lys), tRNA(Ile), and tRNA(His), which previous
studies have identified to be packaged into HIV-1 virions along with
tRNA(3Lys). We demonstrate that infectious viruses which utilized
tRNA(1,2Lys), tRNA(Ile), and tRNA(His) in reverse transcription can be
recovered. However, the appearances of viruses with PBSs complementary to
these alternate tRNAs were delayed compared with the wild type. After
extended in vitro culture, viruses containing the PBSs complementary to
these different tRNAs reverted back to the wild-type PBS complementary to
tRNA3(Lys). Furthermore, only the first 9 nucleotides of the 18 nucleotide
PBSs were sufficient for HIV-1 to utilize the alternate tRNA primers in
reverse transcription, demonstrating that HIV-1 does not require the
complete 18-nucleotide PBS to utilize these tRNA primers for reverse
transcription. These results suggest that factors other than
complementarity between the PBS and the primer tRNA contribute to the
selectivity of tRNA3(Lys) to initiate HIV-1 reverse transcription.
Copyright © 1995, American Society for Microbiology
Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys)
Department of Microbiology, University of Alabama at Birmingham 35294, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|